United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. 0.39%17.896.5%$157.90m
HZNPHorizon Therapeutics Plc -0.45%49.106.5%$135.23m
MYOKMyoKardia, Inc. -1.45%106.991.8%$132.99m
BHCBausch Health Cos., Inc. 2.09%18.530.0%$120.10m
VRXValeant Pharmaceuticals International, Inc. 2.09%18.5314.1%$109.03m
CTLTCatalent, Inc. -3.86%73.542.3%$94.00m
UTHRUnited Therapeutics Corp. -1.39%116.8114.3%$76.76m
AXSMAxsome Therapeutics, Inc. 2.32%78.451.9%$76.61m
AMRNAmarin Corp. Plc -0.86%6.961.6%$66.18m
ICPTIntercept Pharmaceuticals, Inc. -2.67%74.4316.8%$57.81m
GWPHGW Pharmaceuticals Plc -3.55%126.496.2%$56.11m
JAZZJazz Pharmaceuticals Plc 3.71%113.382.4%$55.94m
PRGOPerrigo Co. Plc 1.17%55.516.8%$48.62m
ICLRICON plc -1.92%164.484.3%$45.93m
ARGXargenx SE 0.71%213.620.0%$39.32m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.